Angiotensin II

CAT#: H522373

CAS#:


Description: Angiotensin II is an endogenous potent vasoconstrictor peptide. The amino acid sequence of angiotensin II is Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu. Angiotensin II increases blood pressure by stimulating the Gq protein in vascular smooth muscle cells (which in turn activates an IP3-dependent mechanism leading to a rise in intracellular calcium levels and ultimately causing contraction). In addition, angiotensin II acts at the Na/H exchanger in the proximal tubules of the kidney to stimulate Na reabsorption and H excretion which is coupled to bicarbonate reabsorption. This ultimately results in an increase in blood volume, pressure, and pH. Angiotensin II is degraded to angiotensin III by angiotensinases located in red blood cells and the vascular beds of most tissues. It has a half-life in circulation of around 30 seconds, whereas, in tissue, it may be as long as 15–30 minutes.

img

Synthetic Routes

Angiotensin II - Synthetic Route 1

Angiotensin II route01

Synthetic reference

Angiotensin II - Synthetic Route 2

Angiotensin II route02

Synthetic reference

Angiotensin II - Synthetic Route 3

Angiotensin II route03

Synthetic reference

Angiotensin II - Synthetic Route 4

Angiotensin II route04

Synthetic reference

Angiotensin II - Synthetic Route 5

Angiotensin II route05

Synthetic reference

Angiotensin II - Synthetic Route 6

Angiotensin II route06

Synthetic reference

Castillo Gomez, Juan Daniel; Hagenbach, Adelheid; Abram, Ulrich. Propargyl-Substituted Thiocarbamoylbenzamidines of Technetium and Rhenium: Steps towards Bioconjugation with Use of Click Chemistry. European Journal of Inorganic Chemistry. Volume 2016. Issue 35. Pages 5427-5434. 2016.

Angiotensin II - Synthetic Route 7

Angiotensin II route07

Synthetic reference

Jubilut, Guita Nicolaewsky; Cilli, Eduardo Maffud; Crusca, Edson, Jr.; Silva, Elias Horacio; Okada, Yoshio; Nakaie, Clovis Ryuichi. Comparative investigation of the cleavage step in the synthesis of model peptide resins: implications for Nα-9-fluorenylmethyloxycarbonyl-solid phase peptide synthesis. Chemical & Pharmaceutical Bulletin. Volume 55. Issue 3. Pages 468-470. 2007.